- Details
- Description
Packaging Size:
56T/bottle
Strength:
200mg
Composition:
Capmatinib
Treatment:
cMET Lung Cancer(NSCLC)
Form:
Tablet
Brand:
Campmadx
Quantity Unit:
200mg*56T/Bottle
Manufacturer:
BIGBEAR Pharma,LAOs PDR
Capmatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Non-Small Cell Lung Cancer
Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping 400 mg PO BID Continue until disease progression or unacceptable toxicityDosage Modifications
Dose reductions for adverse reactions- First occurrence: Restart at 300 mg PO BID
- Second occurrence: Restart at 200 mg PO BID
- Unable to tolerate 200 mg PO BID: Permanently discontinue
